Iovance Biotherapeutics Inc.

In News

UBS Raises PT on Iovance Biotherapeutics (IOVA) - Yahoo Finance

Yahoo Finance - Mar 06, 2026

Momentum Shift: Is Iovance Biotherapeutics Inc. stock a bargain at current levels - July 2025 Breakouts & Free Real-Time Market Sentiment Alerts - Naître et grandir

Naître et grandir - Mar 07, 2026

Iovance Biotherapeutics: Short-Term Pain, Long-Term Gain - I'm Still Bullish After All These Years - Seeking Alpha

Seeking Alpha - Mar 04, 2026

Iovance Biotherapeutics (IOVA) Stock Rallies on Analyst Upgrades, Amtagvi Momentum - International Business Times Australia

International Business Times Australia - Mar 07, 2026

Iovance Biotherapeutics stock hits 52-week high at 4.35 USD - Investing.com Nigeria

Investing.com Nigeria - Mar 09, 2026

Iovance Biotherapeutics to Present at Upcoming Conferences - GlobeNewswire

GlobeNewswire - Feb 26, 2026

Key facts: Iovance Biotherapeutics expands TIL therapy; UBS raises price target - TradingView

TradingView - Mar 05, 2026

What's Going On With Iovance Biotherapeutics Stock On Friday? - Benzinga

Benzinga - Mar 06, 2026

Iovance Biotherapeutics: The High‑Risk Cancer Stock I Think Could Change a Portfolio by 2036 - Nasdaq

Nasdaq - Mar 05, 2026

Is Iovance Biotherapeutics Inc. (IOVA) One of the Best Immunotherapy Stocks to Buy According to Hedge Funds? - Yahoo Finance

Yahoo Finance - Feb 19, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

GlobeNewswire - Feb 20, 2026

Iovance Biotherapeutics, Inc. (IOVA): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Jan 15, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment